Using Virtual Reality and digital therapeutics for behavioral health, BehaVR is described as a different kind of digital therapeutics company structured around tackling the epidemic of anxiety-related challenges and disorders, to help curb chronic disease at scale. Partnering with various academic institutions, research institutes and pharmaceutical companies, the effort is to innovate at the intersection of behavioral science, virtual reality and community design to develop immersive, evidence-based experiences that change peoples' lives. Management inidicate that with every program created, the commitment is to give people agency over their own health, and to generate value, change, and better clinical outcomes for all stakeholders in the healthcare system. In December 2022 it was announced that Oxford Science Enterprises' portfolio company - OxfordVR - would combine with BehaVR together to address the mental health crisis with what would be the largest VR delivery platform for evidence-based digital therapeutics
